Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Discover Oncology|September 1, 2022
Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell linesAdelina Plangger, Barbara Rath, Sandra Stickler, et al.
Cells|August 16, 2019
Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung CancerEva Obermayr, Christiane Agreiter, Eva Schuster, et al.
Life Sciences|September 4, 2020
Effects of metformin on adipose-derived stromal cell (ADSC) - Breast cancer cell lines interactionMaryana Teufelsbauer, Barbara Rath, Adelina Plangger, et al.
Investigational New Drugs|August 26, 2019
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell linesMaximilian Hochmair, Barbara Rath, Lukas Klameth, et al.
Medical Oncology (Northwood, London, England)|February 12, 2022
Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactionsMaryana Teufelsbauer, Clemens Lang, Adelina Plangger, et al.
European Journal of Medicinal Chemistry|January 31, 2006
Synthesis of compounds with antiproliferative activity as analogues of prenylated natural products existing in Brazilian propolisLaura Pisco, Marcus Kordian, Klaus Peseke, et al.
Scientific Reports|July 15, 2017
Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistanceLukas Klameth, Barbara Rath, Maximilian Hochmaier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinomaShuren Li, Mohsen Beheshti, Markus Peck-Radosavljevic, et al.
Translational Lung Cancer Research|December 13, 2024
Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutationGerhard Hamilton, Sandra Stickler, Mikhail Ermakov, et al.
Melanoma Research|November 30, 2005
Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo resultsJulia Valencak, Elisabeth Heere-Ress, Tatjana Traub-Weidinger, et al.
Pageof 10